The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 176, S21-S141, 2019 | 765 | 2019 |
The Concise Guide to PHARMACOLOGY 2017/18: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, NV Marrion, ... British journal of pharmacology 174, S17-S129, 2017 | 664 | 2017 |
The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo N Chiang, CN Serhan, SE Dahlén, JM Drazen, DWP Hay, GE Rovati, ... Pharmacological reviews 58 (3), 463-487, 2006 | 612 | 2006 |
The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors SPH Alexander, AP Davenport, E Kelly, N Marrion, JA Peters, HE Benson, ... British journal of pharmacology 172 (24), 5744-5869, 2015 | 576 | 2015 |
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl‐leukotrienes receptor P Ciana, M Fumagalli, ML Trincavelli, C Verderio, P Rosa, D Lecca, ... The EMBO journal 25 (19), 4615-4627, 2006 | 505 | 2006 |
The highly conserved DRY motif of class AG protein-coupled receptors: beyond the ground state GE Rovati, V Capra, RR Neubig Molecular pharmacology 71 (4), 959-964, 2007 | 482 | 2007 |
The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 178, S27-S156, 2021 | 471 | 2021 |
Cysteinyl‐leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends V Capra, MD Thompson, A Sala, DE Cole, G Folco, GE Rovati Medicinal research reviews 27 (4), 469-527, 2007 | 226 | 2007 |
Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7 M Bäck, WS Powell, SE Dahlén, JM Drazen, JF Evans, CN Serhan, ... British journal of pharmacology 171 (15), 3551-3574, 2014 | 216 | 2014 |
Leukotrienes as mediators of asthma S Nicosia, V Capra, GE Rovati Pulmonary pharmacology & therapeutics 14 (1), 3-19, 2001 | 182 | 2001 |
International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions M Bäck, SE Dahlén, JM Drazen, JF Evans, CN Serhan, T Shimizu, ... Pharmacological reviews 63 (3), 539-584, 2011 | 164 | 2011 |
Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke V Capra, M Bäck, SS Barbieri, M Camera, E Tremoli, GE Rovati Medicinal research reviews 33 (2), 364-438, 2013 | 127 | 2013 |
Transcellular biosynthesis of eicosanoid lipid mediators V Capra, GE Rovati, P Mangano, C Buccellati, RC Murphy, A Sala Biochimica et biophysica acta (BBA)-molecular and cell biology of lipids …, 2015 | 109 | 2015 |
Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities V Capra, M Ambrosio, G Riccioni, GE Rovati Current medicinal chemistry 13 (26), 3213-3226, 2006 | 103 | 2006 |
Cysteinyl‐leukotriene receptors and cellular signals GE Rovati, V Capra The Scientific World Journal 7 (1), 1375-1392, 2007 | 97 | 2007 |
CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylation S Ravasi, S Citro, B Viviani, V Capra, GE Rovati Respiratory research 7, 1-18, 2006 | 92 | 2006 |
CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors L Mamedova, V Capra, MR Accomazzo, ZG Gao, S Ferrario, M Fumagalli, ... Biochemical pharmacology 71 (1-2), 115-125, 2005 | 91 | 2005 |
Lower efficacy: interaction with an inhibitory receptor or partial agonism? GE Rovati, S Nicosia Trends in pharmacological sciences 15 (5), 140-144, 1994 | 86 | 1994 |
CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation V Capra, S Ravasi, MR Accomazzo, S Citro, M Grimoldi, MP Abbracchio, ... Journal of cell science 118 (23), 5625-5636, 2005 | 85 | 2005 |
Pranlukast: a review of its use in the management of asthma SJ Keam, KA Lyseng-Williamson, KL Goa Drugs 63 (10), 991-1019, 2003 | 83 | 2003 |